Selecting a Notified Body (NB) is an important (and required) step for obtaining CE Marking and registering your medical device for sale in the European Union. Your Notified Body audits your quality management system and reviews your Technical File to ensure it complies with the appropriate EU Directive.We answer all these questions and more in this 5-page white paper.
About the Author
Jaap Laufer, MD, PharmD is Vice President of Regulatory & Clinical Affairs at Emergo. Dr. Laufer has over 30 years of experience in the medical device and pharmaceuticals industries. He previously held executive and senior regulatory positions at Pfizer, Abbott Laboratories, LipoMatrix, and others. His areas of expertise include a vast array of mostly implant and higher classed products, ISO and FDA QSR audits, and clinical study approvals and compliance. He holds a PharmD in Pharmacy from the University of Groningen and is an MD from the Medical School of the University of Nijmegen, both in The Netherlands. Dr. Laufer is a member of the Medical Devices Expert Group to the EU Commission and teaches at the University of Southern California in Los Angeles, USA.
自2018年起,美国食品和药物管理局(U.S. Food and Drug Administration,FDA)开始试行以电子化方式来帮助行业提供完整的510(k)上市前通知。2022年,为推进以电子格式提供510(k)递交文件的过渡,美国FDA正式发布关于使用电子递交模板和资源的最终指导文
阅读更多自2022年5月26日始,欲在欧盟(EU)上市的新型体外诊断(IVD)医疗器械必须符合欧盟体外诊断医疗器械法规(2017/746 IVDR)。 同日起,带有有效CE标志的IVD可以继续按照指令98/79/EC(IVDD)进行销售,直至其许可证到期为止。 自2025年5月27日始,在欧盟销售的所
阅读更多